BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

762 related articles for article (PubMed ID: 17653268)

  • 21. Cannabinoid receptor agonists and antagonists stimulate insulin secretion from isolated human islets of Langerhans.
    Li C; Bowe JE; Huang GC; Amiel SA; Jones PM; Persaud SJ
    Diabetes Obes Metab; 2011 Oct; 13(10):903-10. PubMed ID: 21564460
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cannabinoid delta-9-tetrahydrocannabinol mediates inhibition of macrophage chemotaxis to RANTES/CCL5: linkage to the CB2 receptor.
    Raborn ES; Marciano-Cabral F; Buckley NE; Martin BR; Cabral GA
    J Neuroimmune Pharmacol; 2008 Jun; 3(2):117-29. PubMed ID: 18247131
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Granulocyte Colony-Stimulating Factor Enhances Brain Repair Following Traumatic Brain Injury Without Requiring Activation of Cannabinoid Receptors.
    Song S; Kong X; Borlongan C; Sava V; Sanchez-Ramos J
    Cannabis Cannabinoid Res; 2021; 6(1):48-57. PubMed ID: 33614952
    [No Abstract]   [Full Text] [Related]  

  • 24. Cannabinoids ameliorate pain and reduce disease pathology in cerulein-induced acute pancreatitis.
    Michalski CW; Laukert T; Sauliunaite D; Pacher P; Bergmann F; Agarwal N; Su Y; Giese T; Giese NA; Bátkai S; Friess H; Kuner R
    Gastroenterology; 2007 May; 132(5):1968-78. PubMed ID: 17484889
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the endocannabinoid system in early human pregnancy.
    Helliwell RJ; Chamley LW; Blake-Palmer K; Mitchell MD; Wu J; Kearn CS; Glass M
    J Clin Endocrinol Metab; 2004 Oct; 89(10):5168-74. PubMed ID: 15472222
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interleukin-2 suppression by 2-arachidonyl glycerol is mediated through peroxisome proliferator-activated receptor gamma independently of cannabinoid receptors 1 and 2.
    Rockwell CE; Snider NT; Thompson JT; Vanden Heuvel JP; Kaminski NE
    Mol Pharmacol; 2006 Jul; 70(1):101-11. PubMed ID: 16611855
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dissecting the role of CB
    Li X; Hempel BJ; Yang HJ; Han X; Bi GH; Gardner EL; Xi ZX
    Eur Neuropsychopharmacol; 2021 Feb; 43():38-51. PubMed ID: 33334652
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cannabinoid CB
    Spiller KJ; Bi GH; He Y; Galaj E; Gardner EL; Xi ZX
    Br J Pharmacol; 2019 May; 176(9):1268-1281. PubMed ID: 30767215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Non-psychoactive CB2 cannabinoid agonists stimulate neural progenitor proliferation.
    Palazuelos J; Aguado T; Egia A; Mechoulam R; Guzmán M; Galve-Roperh I
    FASEB J; 2006 Nov; 20(13):2405-7. PubMed ID: 17015409
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential CB1 and CB2 cannabinoid receptor-inotropic response of rat isolated atria: endogenous signal transduction pathways.
    Sterin-Borda L; Del Zar CF; Borda E
    Biochem Pharmacol; 2005 Jun; 69(12):1705-13. PubMed ID: 15885656
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Similarities and differences upon binding of naturally occurring Δ
    Raïch I; Rivas-Santisteban R; Lillo A; Lillo J; Reyes-Resina I; Nadal X; Ferreiro-Vera C; de Medina VS; Majellaro M; Sotelo E; Navarro G; Franco R
    Pharmacol Res; 2021 Dec; 174():105970. PubMed ID: 34758399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cannabinoid receptors, CB1 and CB2, as novel targets for inhibition of non-small cell lung cancer growth and metastasis.
    Preet A; Qamri Z; Nasser MW; Prasad A; Shilo K; Zou X; Groopman JE; Ganju RK
    Cancer Prev Res (Phila); 2011 Jan; 4(1):65-75. PubMed ID: 21097714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cannabinoid-mediated elevation of intracellular calcium: a structure-activity relationship.
    Rao GK; Kaminski NE
    J Pharmacol Exp Ther; 2006 May; 317(2):820-9. PubMed ID: 16436496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cannabinoid type 1 and type 2 receptor antagonists prevent attenuation of serotonin-induced reflex apneas by dronabinol in Sprague-Dawley rats.
    Calik MW; Carley DW
    PLoS One; 2014; 9(10):e111412. PubMed ID: 25350456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The cannabinoid system and immune modulation.
    Klein TW; Newton C; Larsen K; Lu L; Perkins I; Nong L; Friedman H
    J Leukoc Biol; 2003 Oct; 74(4):486-96. PubMed ID: 12960289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Activation through cannabinoid receptors 1 and 2 on dendritic cells triggers NF-kappaB-dependent apoptosis: novel role for endogenous and exogenous cannabinoids in immunoregulation.
    Do Y; McKallip RJ; Nagarkatti M; Nagarkatti PS
    J Immunol; 2004 Aug; 173(4):2373-82. PubMed ID: 15294950
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular biology of cannabinoid receptors.
    Abood ME
    Handb Exp Pharmacol; 2005; (168):81-115. PubMed ID: 16596772
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cannabinoid receptors CB1 and CB2: a characterization of expression and adenylate cyclase modulation within the immune system.
    Schatz AR; Lee M; Condie RB; Pulaski JT; Kaminski NE
    Toxicol Appl Pharmacol; 1997 Feb; 142(2):278-87. PubMed ID: 9070350
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Endocannabinoids and the gastrointestinal tract: what are the key questions?
    Sanger GJ
    Br J Pharmacol; 2007 Nov; 152(5):663-70. PubMed ID: 17767170
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Substantially altered expression pattern of cannabinoid receptor 2 and activated endocannabinoid system in patients with severe heart failure.
    Weis F; Beiras-Fernandez A; Sodian R; Kaczmarek I; Reichart B; Beiras A; Schelling G; Kreth S
    J Mol Cell Cardiol; 2010 Jun; 48(6):1187-93. PubMed ID: 19931541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.